Pfizer Inc.

Recent Events

News & Analysis

pfizer inc. and pharmaceutical company and sales - All News and Analysis

• Pharma Roundup: Amylin Cuts Jobs, Sanofi Faces Hard Times, and More

  BNET - 2008-11-11

  Amylin cuts 340 jobs, UBS predicts hard times for Sanofi, Pfizer sells a factory and GSK will close one. by John Maas

  Tags: Job, Recruitment & Selection, Human Resources, Workforce Management, John Maas, Pfizer Inc., Pharmaceutical Company, Sales Strategy, Sales Force Management, Sales

• Pharma Roundup: AstraZeneca's Crestor Success, Pfizer's Chantix Problems, and More

  BNET - 2008-11-10

  Highly encouraging results on AZ's Crestor, UK drug regulators echo Chantix suicide concerns, OTC drug marketers struggle, Lilly CEO highlights three "gorillas" dogging pharma. by John Maas

  Tags: AstraZeneca Plc., Pfizer Inc., Pharmaceutical Company, John Maas, Brand, Gorilla, Branding, Sales Strategy, Marketing, Sales

• Pharma Roundup: Glaxo Reorganizing in U.S., Pfizer Urged to Keep Jobs in Connecticut, and More

  BNET - 2008-11-04

  Glaxo reorganizes U.S. operations; Connecticut congressmen ask Pfizer to keep U.S. jobs; AstraZeneca executive Patterson to retire; DTC advertising not earning its keep? by John Maas

  Tags: U.S., Job, Pfizer Inc., Connecticut, Glaxo, Recruitment & Selection, Human Resources, Workforce Management, John Maas, Advertisement, Pharmaceutical Company, Sales Strategy, Sales

• Pharma Roundup: Pfizer Re-Slices Organizational Pie, Lilly Dishes Out Zyprexa Settlement, and More

  BNET - 2008-10-07

  Pfizer reorganizes; Lilly to pay $62 million fine over Zyprexa; biotech losing talent to clean tech; Consumer Reports blacklists 20 drugs for seniors by John Maas

  Tags: Layoff, Pfizer Inc., Settlement, Pharmaceutical Company, Clean Technology, Litigation, Biotechnology, Sales Strategy, Workforce Management, Business Operations, Sales, Human Resources, John Maas

• The 10 Weirdest Drug Stories of the Month

  BNET - 2008-10-01

  Another page has been torn off the calendar, and that means it's time to open up Big Pharma's vault of peculiarities and do a roundup of strange-but-true tales from the world of drugs that surfaced on my radar last month. I give you the 10 weirdest drug...

  Tags: Pfizer Inc., Movie, Pharmaceutical Company, Swedes, AZ, Indevus, Sales Strategy, Workforce Management, Sales, Human Resources, Jim Edwards

• The management behind the molecules: pharmaceutical CEOs outline their key revenue drivers. (Focus 2003: Active Pharmaceutical Ingredients).

  - 2003-03-17

  Many concede that 2003 will be a transition year for the major pharmaceutical companies in terms of new drug development and product launches. That will put an even greater pressure on companies' mainstay products as pharmaceutical executives work Many concede that 2003 will...

  Tags: Aventis, Pfizer Inc., pharmaceutical company, sales

• Is Pharma M&A the Key to Strengthening the Pipeline?(Pharmaceutical industry mergers and acquisitions)(Statistical Data Included)

  - 2000-08-21

  Building critical mass to fund research and development is one of the most significant issues ongoing in the pharmaceutical industry. However, the critical question is whether pharmaceutical mergers and acquisitions really strengthen the drug pipel Building critical mass to fund research and development is...

  Tags: J.P. Morgan Chase & Co., pharmaceutical company, Pfizer Inc., sales, compound, M&A

• Pharma's Consolidation Creates New Kind of Player.(Statistical Data Included)

  - 2000-05-29

  Companies become broader and more efficient. THE RECENT merger and acquisition activity in the drug industry is changing the landscape of pharmaceutical players. Within just the past two years, consolidation has created a new breed of super dr Companies...

  Tags: Aventis, Companies, company, Datamonitor, Merck & Co. Inc., merger, Pfizer Inc., pharmaceutical company, sales, Warner-Lambert

• Pfizer writes its own prescription for growth;Drug company expands via R&D, sales efforts; reaches crossroads as megamerger approaches.

  - 2000-05-15

  when hillary rodham clinton set out to reform the health care system in 1993, pharmaceutical companies, fearful that price controls were on the horizon, ran for cover, spending billions to diversify into new lines of business. The march of managed ca when hillary rodham clinton set...

  Tags: health care, Pfizer Inc., pharmaceutical company, R&D, sales

• Drug Producers Continue To Record Strong Results.

  - 1999-10-25

  W-L and Pfizer lead with strong sales and earnings. THE LARGEST US drug manufacturers are posting third quarter earnings growth in the mid-teens and higher, just as analysts predicted. The industry's leaders include Warner-Lambert Company and W-L and...

  Tags: company, earnings, Pfizer Inc., pharmaceutical company, sales